Bahrain's National Health Regulatory Authority (NHRA) has approved Wegovy (semaglutide) pills, an oral GLP-1 treatment for obesity, in the kingdom. With this, Bahrain has become the second GCC country, after the UAE, and the fifth country worldwide to make the medicine available to its citizens.
